US Patent Issued to The General Hospital on April 14 for "Chimeric antigen receptors targeting CD79B and CD19" (Massachusetts Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,760, issued on April 14, was assigned to The General Hospital Corp. (Boston).

"Chimeric antigen receptors targeting CD79B and CD19" was invented by Marcela V. Maus (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are upfront methods for treating a patient suffering from a cancer. The method includes administering to the patient a therapeutically effective amount of an anti-cancer therapy including a chimeric antigen receptor (CAR) including an extracellular domain including a CD79b-binding domain and a CD19-binding domain, wherein the patient has not been previously treated for the cancer. The invention accordingly ...